02126nam a2200445 i 4500 ocn954068048 BD 20161013074337.0 he bmb024bbca 160727s2016 dcu bb f000 0 eng c PUCPR eng rda GPO spa pcc n-us--- BDDF KF26 .L27 2013 1043-B (MF) Y 4.L 11/4:S.HRG.113-756 Y 4.L 11/4:S.HRG.113-756 United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions, author. Pharmaceutical compounding: proposed legislative solution : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Thirteenth Congress, first session ... May 9, 2013. Washington : U.S. Government Publishing Office, 2016. Washington, DC : For sale by the Superintendent of Documents, U.S. Government Publishing Office iii, 60 pages ; 24 cm. text txt rdacontent microform h rdamedia microfiche he rdacarrier S. hrg. ; 113-756 Shipping list no.: 2016-0157-M. CRDP Project record. Includes bibliographical references. Microfiche. [Washington, D.C.] : U.S. Government Printing Office, [2016] 1 microfiche : negative. Drugs Dosage forms United States. Drug adulteration Law and legislation United States. Legislative hearings. lcgft Print version: United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. Pharmaceutical compounding: proposed legislative solution (DLC) 2015464810 (OCoLC)945969489 Online version: United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. Pharmaceutical compounding: proposed legislative solution (OCoLC)945923731 United States. Congress. Senate. S. hrg. ; 113-756. sudocs 12 254770 254770 0 0 sudocs 0 0 7 7 5 2016-10-13 GPO 0.00 0 Y 4.L 11/4:S.HRG.113-756 Y4L114113756 2016-10-13 00:00:00 2016-10-13 12